Miguel Abboud to Pyrazoles
This is a "connection" page, showing publications Miguel Abboud has written about Pyrazoles.
Connection Strength
0.371
-
Voxelotor for the treatment of sickle cell disease in pediatric patients. Expert Rev Hematol. 2022 06; 15(6):485-492.
Score: 0.180
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
Score: 0.146
-
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
Score: 0.045